Conversely, CD19 on IgD- CD38br (B cell panel; Odds ratio:1.1429, 95%CI:1.0821-1.2071, p-value:1.64×10−6) was associated with an increased risk of breast cancer across the IVW method, weighted mode, and weighted median. This evidence concerns the gene CD19 and breast carcinoma.